These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9527783)

  • 1. Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.
    Collins LA; Torrero MN; Franzblau SG
    Antimicrob Agents Chemother; 1998 Feb; 42(2):344-7. PubMed ID: 9527783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter.
    Changsen C; Franzblau SG; Palittapongarnpim P
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3682-7. PubMed ID: 14638465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
    Collins L; Franzblau SG
    Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
    Joloba ML; Bajaksouzian S; Jacobs MR
    J Clin Microbiol; 2000 Oct; 38(10):3834-6. PubMed ID: 11015413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.
    Deb DK; Srivastava KK; Srivastava R; Srivastava BS
    Biochem Biophys Res Commun; 2000 Dec; 279(2):457-61. PubMed ID: 11118308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages.
    Srivastava R; Deb DK; Srivastava KK; Locht C; Srivastava BS
    Biochem Biophys Res Commun; 1998 Dec; 253(2):431-6. PubMed ID: 9878553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
    Wanger A; Mills K
    J Clin Microbiol; 1996 Jul; 34(7):1672-6. PubMed ID: 8784567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1610-6. PubMed ID: 8807049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of proportion method in Löwenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates].
    Gül Yurtsever S; Biçmen C; Gündüz AT; Ozkütük N; Salman S; Demirci M
    Mikrobiyol Bul; 2011 Oct; 45(4):623-31. PubMed ID: 22090293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.
    Norden MA; Kurzynski TA; Bownds SE; Callister SM; Schell RF
    J Clin Microbiol; 1995 May; 33(5):1231-7. PubMed ID: 7615733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
    Heifets L
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
    Ceyhan İ; Vezir S
    Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis.
    Leonard B; Coronel J; Siedner M; Grandjean L; Caviedes L; Navarro P; Gilman RH; Moore DA
    J Clin Microbiol; 2008 Oct; 46(10):3526-9. PubMed ID: 18701659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A whole blood bactericidal assay for tuberculosis.
    Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
    J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
    Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
    Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.